By Justin Yamashita, MSc. Benchtop, site, CRO: three levels of basic and clinical research, explained without spin.

From Open Label Media, the team of one behind Root to Rx, comes a quiz to find out your type of skepticism, plus four free interactive games for discussions about claims made online and telling what’s true.

The Root Room is where the ideas from Plain Talk come to life through people. Catching up takes a minute: in recent rooms we met a pharmacist, a worried parent, and a coordinator named Nani who runs a clinical trial site. This week the Pipeline Crew takes over, the people whose job is to make sure the data behind your medicine is real: Mira the traveling monitor (CRA), Asha in centralized monitoring, Devon the data manager, Priya the trial manager, Dr. Reyes the medical monitor, and Tomas in pharmacovigilance. Together they are the reason the risk list on a drug ad means anything.

Mira lives out of a carry-on. She's a Clinical Research Associate (CRA), commonly referred to as a monitor, and today she's monitoring Nani's site. She opens a laptop, pulls the records, and starts comparing what the patient file says against what actually happened in the electronic medical records and patient binder (we call this the source, the first instance data is documented). The visit dates align, lab values match the source, the informed consent forms are signed and dated before any other study procedures began. Coordinator Nani runs a tight ship, and Mira tells her so. This is a well-run clinical trial site, with people who truly care about patient safety and data integrity.

Far removed from any clinical trial site, Asha the centralized monitoring manager, also commonly known as a data analytics manager, watches all the data. She runs data analysis, looking for patterns across every location in the study. One site's numbers are too consistent across different visits over time. The lab values cluster in a way real biology rarely does. She pulls it up for Devon, the data manager, who has been chasing the same site with queries that keep coming back wrong. Queries are questions entered into the portal where source data is entered. Such as, “the patient's weight at visit 5 was the exact same as for visit 4, 3 weeks apart, please reconfirm this is correct?”

They take it to Priya, the trial manager. Priya doesn't panic; instead, she escalates. This is a breadcrumb that she needs to send Mira to investigate.

Priya gets Mira to book the visit and does the math on her staff. The monitoring budget got trimmed this year, so the team is smaller and the sites per monitor went up. The work didn't shrink, and the net got thinner. She makes it work, because the alternative is not looking. The advancement of centralized monitoring makes a huge difference, letting the team monitor the most critical data points and use technology to find trends the naked human eye may not always catch. This room has evolved over the decades of clinical research. Instead of monitoring every single data point, reduced monitoring strategies based on risk and data criticality have changed the process without sacrificing safety.

Mira flies out to the flagged site, run by Dr. Voss.

The site files look fine at a glance. Then something catches her well trained eye. A study visit recorded on a national holiday when the clinic was closed. Source notes that don't match the database. An audit trail showing values entered, then edited weeks later.

Mira doesn't say the word fraud. She writes down exactly what she sees, pulls copies where she's allowed, and keeps her questions careful. Just like everything else in clinical research, she documents everything and escalates to her clinical trial manager, Priya.

On average, CRAs are living out of hotel rooms 3-4 nights per week while they audit research sites. That night, from the latest hotel room, Mira calls Priya. Picking up from the email she sent earlier, because if it is not written down it didn't happen, she talks through what she found. The finding starts to climb.

Sponsor project management, clinical trial management, quality, and data management signing on, while the CRO project management, clinical trial manager Priya, wait for their counterparts to funnel into the call. A debrief of findings, and alignment on paths forward result in a for-cause audit being launched. The ethics board that approved the study is notified. The clock for reporting a serious breach starts, and the most important thing happens quietly throughout the process: the data from Dr. Voss's site is pulled out of the analysis. The medicine that reaches a real patient will not be built on invented numbers. If it goes further, the regulators have their own ladder by way of an inspection, a formal notice, and a path that can bar an investigator for good.

Cora, the Heart of the Root Room, who feels everything the rest of them are too busy to say, puts it plainly: somewhere there's a patient who will take this drug and never know how close a stranger's lie came to reaching them, and never know that a tired woman bouncing between hotels and states is the reason it didn't. In future issues, we'll talk about how clinical trials are designed, how they are launched with meticulous planning to ensure safety nets and checks are in place to catch scientific misconduct, and maximize safety.

With the invented data pulled out, what's left is real, and now it has to become the list a television or YouTube ad will one day read. Dr. Reyes, the medical monitor, has watched the serious events all along, working with investigators at sites worldwide in real time for which ones were serious, which were unexpected, and which were plausibly the drug. Tomas, in pharmacovigilance, codes each event to a standard dictionary, counts it across every patient, and works with his team to file the urgent ones to regulators while the study still runs so that investigators worldwide can keep extra attention to look for them.

A coder turns woozy and stomach off into terms that count the same way everywhere. A biostatistician turns those counts into rates, this event on the drug, that event on placebo. What survives becomes the label, and the label is what the ad must read out loud.

That is the receipt from Plain Talk, written by hand, one verified event at a time. The scary list is not the sound of a dangerous drug. It's the sound of every one of these people having done their job because the clinical trial gives data on what could statistically happen when a drug makes it to market. Such as if a 1 in 100 chance someone develops a fever is caught in a study with 300 patients, 3 of the trial participants may have experienced it. However, in a study with 300 patients, it may not catch something that only happens in 1 out of 10,000 patients. That could appear after clinical trials.

The system isn't perfect. People cheat, but there are safety nets, and this week it held. Now picture that same net with half as many people holding it. That's not an abstract budget line. That's how a Dr. Voss gets through. Principle to practice: the watching is the product. It's worth paying for, and it's worth defending.

The views expressed on Root to Rx are my own and do not represent the views or positions of my employer, or any affiliated organization.

Root to Rx | 228 Park Ave S, #29976, New York, New York 10003, United States

You are receiving this because you subscribed at roottorx.com. To unsubscribe, click the link below.